Neogenomics (NEO) Share-based Compensation Growth (1y) (2011 - 2026)
Neogenomics (NEO) Share-based Compensation Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 53.85% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 10.67% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -4.92% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 11.80% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 22.20% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 6.67% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -9.72% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -17.81% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 6.42% |
| 10 | Neogenomics | 1.93 Bn | 1.79 Bn | 80.86 Mn | -10.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.40% |
| Dec 31, 2025 | -3.43% |
| Jun 30, 2025 | 12,114.00% |
| Mar 31, 2025 | 38.33% |
| Dec 31, 2024 | 19.14% |
| Mar 31, 2024 | 63.39% |
| Dec 31, 2023 | 49.90% |
| Mar 31, 2023 | -60.69% |
| Dec 31, 2022 | -53.66% |
| Sep 30, 2022 | -18.27% |
| Jun 30, 2022 | -19.53% |
| Mar 31, 2022 | 356.20% |
| Dec 31, 2021 | 276.01% |
| Sep 30, 2021 | 92.89% |
| Jun 30, 2021 | 71.01% |
| Mar 31, 2021 | 21.36% |
| Dec 31, 2020 | 17.73% |
| Sep 30, 2020 | -17.10% |
| Jun 30, 2020 | 13.92% |
| Mar 31, 2020 | 2.20% |